Grifols
Company Details
Linkedin ID:
grifols
Website:
Employees number:
12,388
Number of followers:
285,293
NAICS:
3254
Industry Type:
Homepage:
linktr.ee
IP Addresses:
151
Company ID:
GRI_7337752
Scan Status:
Completed
Grifols Company CyberSecurity Posture
linktr.ee
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2025, Grifols was named one of TIME’s ‘World’s Best Companies’ for the third year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best World Employers 2025," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.
Grifols A.I CyberSecurity Scoring
Grifols Risk Score (AI oriented)Between 750 and 799
Grifols
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Grifols Global Score (TPRM)XXXX
Grifols
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Grifols Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Grifols Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Grifols
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Grifols in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Grifols in 2025.
Incident Types Grifols vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Grifols in 2025.
Incident History — Grifols (X = Date, Y = Severity)
Grifols cyber incidents detection timeline including parent company and subsidiaries
Grifols Company Subsidiaries
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2025, Grifols was named one of TIME’s ‘World’s Best Companies’ for the third year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best World Employers 2025," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.
Loading...
Grifols Similar Companies
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine
MANKIND PHARMA LTD
Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,
Dr. Reddy's Laboratories
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics
Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage
Ipca Laboratories Limited
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
Johnson & Johnson Innovative Medicine
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. By combining t
.png)
Grifols CyberSecurity News
October 15, 2025 07:00 AM
This Week’s Health IT Jobs – October 15, 2025
It can be very overwhelming scrolling through job board after job board in search of a position that fits your wants and needs.
May 24, 2024 07:00 AM
Cencora data breach exposes patient data at top pharma firms
The Cencora breach affected some of the most prominent Big Pharma firms, including Novartis, Bayer, AbbVie, Regeneron, Genentech and Incyte.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Grifols CyberSecurity History Information
Official Website of Grifols
The official website of Grifols is https://linktr.ee/Grifols.
Grifols’s AI-Generated Cybersecurity Score
According to Rankiteo, Grifols’s AI-generated cybersecurity score is 776, reflecting their Fair security posture.
How many security badges does Grifols’ have ?
According to Rankiteo, Grifols currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Grifols have SOC 2 Type 1 certification ?
According to Rankiteo, Grifols is not certified under SOC 2 Type 1.
Does Grifols have SOC 2 Type 2 certification ?
According to Rankiteo, Grifols does not hold a SOC 2 Type 2 certification.
Does Grifols comply with GDPR ?
According to Rankiteo, Grifols is not listed as GDPR compliant.
Does Grifols have PCI DSS certification ?
According to Rankiteo, Grifols does not currently maintain PCI DSS compliance.
Does Grifols comply with HIPAA ?
According to Rankiteo, Grifols is not compliant with HIPAA regulations.
Does Grifols have ISO 27001 certification ?
According to Rankiteo,Grifols is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Grifols
Grifols operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Grifols
Grifols employs approximately 12,388 people worldwide.
Subsidiaries Owned by Grifols
Grifols presently has no subsidiaries across any sectors.
Grifols’s LinkedIn Followers
Grifols’s official LinkedIn profile has approximately 285,293 followers.
NAICS Classification of Grifols
Grifols is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Grifols’s Presence on Crunchbase
No, Grifols does not have a profile on Crunchbase.
Grifols’s Presence on LinkedIn
Yes, Grifols maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/grifols.
Cybersecurity Incidents Involving Grifols
As of December 11, 2025, Rankiteo reports that Grifols has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Grifols has an estimated 5,412 peer or competitor companies worldwide.
Grifols CyberSecurity History Information
How many cyber incidents has Grifols faced ?
Total Incidents: According to Rankiteo, Grifols has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Grifols ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=grifols' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
